241 related articles for article (PubMed ID: 19283074)
1. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.
Kron K; Pethe V; Briollais L; Sadikovic B; Ozcelik H; Sunderji A; Venkateswaran V; Pinthus J; Fleshner N; van der Kwast T; Bapat B
PLoS One; 2009; 4(3):e4830. PubMed ID: 19283074
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH
J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325
[TBL] [Abstract][Full Text] [Related]
5. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
6. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
Mavis CK; Morey Kinney SR; Foster BA; Karpf AR
Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856
[TBL] [Abstract][Full Text] [Related]
7. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.
Yamamoto M; Cid E; Bru S; Yamamoto F
PLoS One; 2011 Mar; 6(3):e17149. PubMed ID: 21423795
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
10. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
[TBL] [Abstract][Full Text] [Related]
14. Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.
Stott-Miller M; Zhao S; Wright JL; Kolb S; Bibikova M; Klotzle B; Ostrander EA; Fan JB; Feng Z; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1331-9. PubMed ID: 24718283
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.
Sloane MA; Wong JW; Perera D; Nunez AC; Pimanda JE; Hawkins NJ; Sieber OM; Bourke MJ; Hesson LB; Ward RL
Epigenetics; 2014 Aug; 9(8):1092-100. PubMed ID: 24837038
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
17. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]